Healthy Skepticism Library item: 16146
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Jureidini J, Clothier R.
Elsevier should divest itself of either its medical publishing or pharmaceutical services division
Lancet 2009 Aug 1; 374:(9687): 375
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)61404-5/fulltext
Abstract:
Elsevier, publisher of The Lancet , is reviewing its publishing practice after court disclosure that it colluded with Merck to produce a fake journal, the Australasian Journal of Bone and Joint Medicine (AJBJM) to promote rofecoxib and other Merck products. Elsevier has called the incident an “isolated practice led by former employees in a local pharmaceutical services divisionâ€. 1 This statement refers to the publication in Australia of nine fake journals, and the registration of another 13. Although …
